← Ticker index
CAH
Ticker
CAH
Congressional Trades
17
by 4 members
Ticker disclosure brief
Congressional disclosure records for CAH
A ticker-first view of recent disclosures, reported ranges, filing lags, party aggregates, federal awards, lobbying records, and source-linked receipts.
Latest receipt
Ro Khanna
SELL · 2026-02-05
Largest range
$50K – $100K
Jonathan Jackson
Longest observed gap
123d
John James
Highest 30d vs SPY
92.9%
John James
Purchase rows
9
53%
Sale rows
8
47%
Disclosed midpoint
$203K
range estimate
Unique Traders
4
members
Disclosure timing method
Observed filing gaps are not notice-date findings
The reporting deadline is the earlier of 30 days after notice or 45 days after the transaction. Public disclosure rows provide transaction and filing dates, but do not establish when a member received notice. PoliWealth therefore marks only transaction-to-filing gaps over 45 days as an apparent delay for review; 31–45 day gaps are not labeled late from transaction date alone.
Party Breakdown
Democrats9 · 53%
Republicans8 · 47%
Federal awards
all →- 2026-07-09$42KDepartment of Health and Human ServicesFLOXURIDINE 500MG VIALS CARDINAL HEALTH 108, LLC:1296676 [26-006059]
- 2026-06-29$395KDepartment of Veterans AffairsNUCLEAR MEDICINE RADIOPHARMACEUTICALS
- 2026-06-29$305KDepartment of Veterans AffairsRADIOPHARMACEUTICALS FOR BUFFALO VA BASE YEAR DELIVERY/TASK ORDER.
- 2026-06-18$19KDepartment of Veterans AffairsMARIBAVIR (LIVTENCITY) 200MG
- 2026-06-18$0Department of Veterans AffairsRADIOPHARMACEUTICALS FOR BUFFALO VA
- 2026-06-16$19KDepartment of Veterans AffairsMARIBAVIR (LIVTENCITY) 200MG (NDC 64764-0800-56)
- 2026-06-16$19KDepartment of Veterans AffairsLIVTENCITY 200 MG
- 2026-06-15$18KDepartment of Veterans AffairsCOMPRESSION DEVICE LEASE - 82106 SCD SMARTFLOW US
- 2026-06-08$46KDepartment of Health and Human ServicesCARDINAL HEALTH 108, LLC:1296676 [26-001378]
- 2026-05-29$655KDepartment of Veterans AffairsRADIOPHARMACEUTICAL SUPPLIES EO 14398
Lobbying filings
all →- 2026-07-14$0CARDINAL HEALTH INC.
- 2026-04-20$1.3MCARDINAL HEALTH INCIssues related to drug pricing, bona fide service fees, pharmacies, provider status, biosimilars, cell and gene therapy, food is medicine; Issues related to provider reimbursement, Medicare and Medicaid, workforce shortages, and product shortages; Issues related to Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS), competitive bidding, reimbursement to home health agencies, and acute hospital care at home services; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act; H.R. 5031/S. 3159, Preserving Patient Access to Long-Term Care Pharmacies Act; H.R. 3164/S. 2426, Ensuring Community Access to Pharmacist Services Act; Education around issues facing independent physicians, including S.3822, the Break Up Big Medicine Act. Education on supply chain issues, drug shortages, domestic manufacturing, medical device environmental issues; Issues related to the medical supply chain and transportation. Issues related to tariffs, trade, and U.S. trade p
- 2026-04-20$120KCARDINAL HEALTHProvide strategic counsel and advocate on issues related to health, tax and trade policy Provide strategic counsel and advocate on issues related to health, tax and trade policy Provide strategic counsel and advocate on issues related to health, tax and trade policy
- 2026-04-20$80KCARDINAL HEALTH (F.K.A. THE GLOVER PARK GROUP)General issues related to drug shortages, supply chain Federal budget issues
- 2026-04-20$30KCARDINAL HEALTH INC.Health care and FDA/agriculture appropriations. Enteral nutrition.
- 2026-04-17$60KCARDINAL HEALTH INC.General issues affecting the health care industry such as drug pricing, pharmaceutical drugs, medical devices, workforce shortages, and product shortages. Pharmaceutical tariffs
- 2026-04-17$24KCARDINAL HEALTH INC.Issues related to the distribution and sale of pharmaceutical and medical products and services; medical and public health preparedness; drug shortages; Food as Medicine; and the healthcare supply chain. Issues related to the distribution and sale of pharmaceutical and medical products and services; medical and public health preparedness; drug shortages; Food as Medicine; and the healthcare supply chain. Issues related to the distribution and sale of pharmaceutical and medical products and services; medical and public health preparedness; drug shortages; and the healthcare supply chain. Issues related to the distribution and sale of pharmaceutical and medical products and services; medical and public health preparedness; drug shortages; Food as Medicine; and the healthcare supply chain. H.R. 4121/S. 2256, FY 2026 Agriculture Appropriations; and H.R. 5304/S. 2587, FY 2026 Labor-HHS Appropriations. Tariff-related matters regarding the distribution and sale of pharmaceutical and m
- 2026-01-20$740KCARDINAL HEALTH INCIssues related to drug pricing, bona fide service fees, Affordable Care Act subsidies, pharmacies, provider status, biosimilars, cell and gene therapy, food is medicine; issues related to provider reimbursement, Medicare and Medicaid, workforce shortages, and product shortages (H.R.4299 Protecting Patient Access to Cancer and Complex Therapies Act; H.R.5031 Preserving Patient Access to Long-Term Care Pharmacies Act; H.R.3164/S.2426 Ensuring Community Access to Pharmacist Services Act). Issues related to DMEPOS supplies, competitive bidding, reimbursement to home health agencies, and acute hospital care at home services (H.R.5142 Home Health Stabilization Act of 2025; H.R. 4313 Hospital Inpatient Services Modernization Act). Education on supply chain issues, drug shortages, domestic manufacturing, medical device environmental issues; Issues related to the medical supply chain and transportation. Issues related to tariffs, trade, and U.S. trade policy. Issues related to tariffs, tr
- 2026-01-20$120KCARDINAL HEALTHProvide strategic counsel and advocate on issues related to health, tax and trade policy Provide strategic counsel and advocate on issues related to health, tax and trade policy Provide strategic counsel and advocate on issues related to health, tax and trade policy
- 2026-01-20$80KCARDINAL HEALTH (F.K.A. THE GLOVER PARK GROUP)General issues related to drug shortages, supply chain Federal budget issues
Loading trade analytics…
All Disclosed Trades
Page 1 · 17 of 17 shown| Date | Member | Action | Amount | Observed Gap | Receipt |
|---|---|---|---|---|---|
| 2026-02-05 | DRo Khanna | SELL | $1K – $15K | 32d | receipt → |
| 2026-02-05 | DRo Khanna | SELL | $1K – $15K | 32d | receipt → |
| 2026-01-23 | DRo Khanna | SELL | $1K – $15K | 14d | receipt → |
| 2026-01-23 | DRo Khanna | SELL | $1K – $15K | 14d | receipt → |
| 2025-09-05 | DRo Khanna | SELL | $1K – $15K | 28d | receipt → |
| 2025-09-05 | DRo Khanna | SELL | $1K – $15K | 28d | receipt → |
| 2025-04-08 | RRobert Bresnahan | BUY | $1K – $15K | 30d | receipt → |
| 2025-04-08 | RRobert Bresnahan | BUY | $1K – $15K | 30d | receipt → |
| 2024-08-02 | DRo Khanna | BUY | $1K – $15K | 35d | receipt → |
| 2024-08-02 | DRo Khanna | BUY | $1K – $15K | 35d | receipt → |
| 2024-09-04 | RJohn James | SELL | $1K – $15K | 2d | receipt → |
| 2024-09-04 | RJohn James | SELL | $1K – $15K | 2d | receipt → |
| 2024-05-02 | RJohn James | BUY | $1K – $15K | 123dApparent delay | receipt → |
| 2024-05-02 | RJohn James | BUY | $1K – $15K | 123dApparent delay | receipt → |
| 2024-06-03 | RJohn James | BUY | $1K – $15K | 91dApparent delay | receipt → |
| 2024-06-03 | RJohn James | BUY | $1K – $15K | 91dApparent delay | receipt → |
| 2024-01-12 | DJonathan Jackson | BUY | $50K – $100K | 24d | receipt → |
“Observed gap” is the calendar distance from transaction date to filing date; only gaps over 45 days receive an apparent-delay marker.